Review of the Clinical Evidence for the Use of DEBIRI in the Treatment of Colorectal Metastatic Disease

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Colorectal cancer is a common malignancy that most commonly metastasizes to the liver. There has been considerable effort in developing new treatment options for these patients. One method that has been developed for the treatment of colorectal metastases to the liver is irinotecan-loaded drug-eluting bead (DEBIRI) embolization. This article reviews the current literature on DEBIRI and discusses the state of current knowledge and possible areas of future investigation.

Original languageEnglish (US)
Pages (from-to)496-501
Number of pages6
JournalCardiovascular and Interventional Radiology
Volume40
Issue number4
DOIs
StatePublished - Apr 1 2017

Fingerprint

irinotecan
Liver
Colorectal Neoplasms
Neoplasm Metastasis
Therapeutics
Pharmaceutical Preparations
Neoplasms

Keywords

  • Colon cancer
  • Drug elutting beads
  • Transarterial chemoembolization (TACE)

Cite this

@article{6276af38547842369c5be120f8473664,
title = "Review of the Clinical Evidence for the Use of DEBIRI in the Treatment of Colorectal Metastatic Disease",
abstract = "Colorectal cancer is a common malignancy that most commonly metastasizes to the liver. There has been considerable effort in developing new treatment options for these patients. One method that has been developed for the treatment of colorectal metastases to the liver is irinotecan-loaded drug-eluting bead (DEBIRI) embolization. This article reviews the current literature on DEBIRI and discusses the state of current knowledge and possible areas of future investigation.",
keywords = "Colon cancer, Drug elutting beads, Transarterial chemoembolization (TACE)",
author = "Young, {Shamar J} and D'Souza, {Donna L} and Flanagan, {Siobhan M} and Jafar Golzarian",
year = "2017",
month = "4",
day = "1",
doi = "10.1007/s00270-016-1537-5",
language = "English (US)",
volume = "40",
pages = "496--501",
journal = "CardioVascular and Interventional Radiology",
issn = "7415-5101",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Review of the Clinical Evidence for the Use of DEBIRI in the Treatment of Colorectal Metastatic Disease

AU - Young, Shamar J

AU - D'Souza, Donna L

AU - Flanagan, Siobhan M

AU - Golzarian, Jafar

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Colorectal cancer is a common malignancy that most commonly metastasizes to the liver. There has been considerable effort in developing new treatment options for these patients. One method that has been developed for the treatment of colorectal metastases to the liver is irinotecan-loaded drug-eluting bead (DEBIRI) embolization. This article reviews the current literature on DEBIRI and discusses the state of current knowledge and possible areas of future investigation.

AB - Colorectal cancer is a common malignancy that most commonly metastasizes to the liver. There has been considerable effort in developing new treatment options for these patients. One method that has been developed for the treatment of colorectal metastases to the liver is irinotecan-loaded drug-eluting bead (DEBIRI) embolization. This article reviews the current literature on DEBIRI and discusses the state of current knowledge and possible areas of future investigation.

KW - Colon cancer

KW - Drug elutting beads

KW - Transarterial chemoembolization (TACE)

UR - http://www.scopus.com/inward/record.url?scp=85006998513&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006998513&partnerID=8YFLogxK

U2 - 10.1007/s00270-016-1537-5

DO - 10.1007/s00270-016-1537-5

M3 - Article

C2 - 28004168

AN - SCOPUS:85006998513

VL - 40

SP - 496

EP - 501

JO - CardioVascular and Interventional Radiology

JF - CardioVascular and Interventional Radiology

SN - 7415-5101

IS - 4

ER -